Inhibitory effects of sulfenimides on human and bovine carbonic anhydrase enzymes

J Enzyme Inhib Med Chem. 2023 Dec;38(1):2194573. doi: 10.1080/14756366.2023.2194573.

Abstract

A series of sulfenimide derivatives (1a-i) were investigated as inhibitors of human (hCA-I, hCA-II) and bovine (bCA) carbonic anhydrase enzymes. The compounds were synthesised by the reaction of substituted thiophenols with phthalimide by means of an effective, simple and eco-friendly method and the structures were confirmed by IR, 1H NMR, 13C NMR, MS and elemental analysis. All derivatives except for the methyl derivative (1b) exhibited effective inhibitory action at low micromolar concentrations on human isoforms, but only four derivatives (1e, 1f, 1h, 1i) inhibited the bovine enzyme. The bromo derivative (1f) was found to be strongest inhibitor of all three enzymes with KI values of 0.023, 0.044 and 20.57 µM for hCA-I, hCA-II and bCA, respectively. Results of our study will make valuable contributions to carbonic anhydrase inhibition studies for further investigations since inhibitors of this enzyme are important molecules for medicinal chemistry.

Keywords: Carbonic anhydrase; inhibitor; phthalimide; sulfenimide; thiophenol.

MeSH terms

  • Animals
  • Carbonic Anhydrase I
  • Carbonic Anhydrase II
  • Carbonic Anhydrase Inhibitors / chemistry
  • Carbonic Anhydrase Inhibitors / pharmacology
  • Carbonic Anhydrases* / chemistry
  • Cattle
  • Humans
  • Molecular Structure
  • Structure-Activity Relationship

Substances

  • Carbonic Anhydrases
  • Carbonic Anhydrase I
  • Carbonic Anhydrase II
  • Carbonic Anhydrase Inhibitors

Grants and funding

This study was supported by Ondokuz Mayıs University [Grant No. PYO.FEN.1904.10.024].